Severe hypoglycaemia, defined as a blood glucose concentration so low that cognitive function is impaired and third-party assistance required1, remains a feared complication of insulin therapy for people with type 1 diabetes (T1D). The gene discussed is INS; the disease is type 1 diabetes mellitus.